Speaker Information

 Linda M Katz
Linda M Katz Director, Office of Cosmetics & Colors FDA
Dr. Linda Katz has held a variety of positions at the FDA.  Since 2002 she has been the Director for the Office of Cosmetics and Colors (OCAC), has served as Chief Medical Officer in FDA’s Center for Food Safety and Applied Nutrition (CFSAN) since 2007, and was the Acting Deputy Director for Operations at CFSAN from September 2012 through March 2013.  In these positions, she establishes the priorities and missions of OCAC, focusing on cosmetic safety, compliance, certification of color additives research, such as nanotechnology, photoxicity and percutaneous absorption, and addressing safety and medical concerns for CFSAN regulated products. She has had numerous presentations and publications, including those related to nanotechnology from a cosmetic and food perspective, as well as other specific cosmetic and food issues.  Prior to assuming leadership of OCAC, she began her FDA career in the Center for Drug Evaluation and Research (CDER), holding positions of Deputy Director for the Division of Over-the-Counter Drug Products, Deputy Director for the Division of Dermatologic and Dental Drug Products, and Team Leader and Acting Director for the Pilot Drug Evaluation Staff.  Dr. Katz received her B.A. in biology from the University of Pennsylvania, her M.D. from the University of Connecticut and a M.P.H. in epidemiology from the University of Michigan School of Public Health.  She completed her internship and residency in Internal Medicine, and fellowship in Rheumatology, at the George Washington University Medical Center, in Washington, D.C.  She is a Fellow in the American College of Physicians and a Fellow Member of the American College of Rheumatology and is boarded in both Internal Medicine and Rheumatology.  In addition, Dr. Katz maintains an academic appointment, as Associate Clinical Professor of Medicine, at The Uniformed Services University of the Health Sciences.  In her latter position she continues to teach and sees patients at Walter Reed National Military Medical Center.

Conference Day One

1:30 PM An Insight to US Regulation: Understanding the FDA's Priorities for 2015/2016 to Ensure Efficient Practices

  • An introduction to the FDA and the priorities for 2015/2016
  • An insight to the US process: clarifying the regulations in the US
  • Tackling the perceived  ambiguity in US regulation: addressing the grey area
  • A look at common mistakes in cosmetic submissions and ways to combat them